Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Life Sciences
|
May 21, 1981
Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid)
J Grove, P J Schechter, G Tell, et al.
The EMBO Journal
|
September 16, 1996
A molecular code dictates sequence-specific DNA recognition by homeodomains
G Damante, L Pellizzari, G Esposito, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
The Biochemical Journal
|
February 28, 1998
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains
G Tell, L Perrone, D Fabbro, et al.
Transplantation Proceedings
|
August 19, 2007
Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver
C Avellini, U Baccarani, G Trevisan, et al.
Journal of Molecular Endocrinology
|
February 5, 2005
A differential proteomic approach to identify proteins associated with thyroid cell transformation
I Paron, C D'Ambrosio, A Scaloni, et al.
Oncogene
|
July 9, 2013
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology
C Vascotto, L Lirussi, M Poletto, et al.
Oncogene
|
June 26, 2015
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology
C Vascotto, L Lirussi, M Poletto, et al.
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Cell Death & Disease
|
May 8, 2015
Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice
G Bortolussi, E Codarin, G Antoniali, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Life Sciences
|
May 21, 1981
Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid)
J Grove, P J Schechter, G Tell, et al.
The EMBO Journal
|
September 16, 1996
A molecular code dictates sequence-specific DNA recognition by homeodomains
G Damante, L Pellizzari, G Esposito, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
A M Bonnet, G Tell, P J Schechter, et al.
The Biochemical Journal
|
February 28, 1998
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains
G Tell, L Perrone, D Fabbro, et al.
Transplantation Proceedings
|
August 19, 2007
Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver
C Avellini, U Baccarani, G Trevisan, et al.
Journal of Molecular Endocrinology
|
February 5, 2005
A differential proteomic approach to identify proteins associated with thyroid cell transformation
I Paron, C D'Ambrosio, A Scaloni, et al.
Oncogene
|
July 9, 2013
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology
C Vascotto, L Lirussi, M Poletto, et al.
Oncogene
|
June 26, 2015
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology
C Vascotto, L Lirussi, M Poletto, et al.
Neurology
|
February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration
G Tell, P Böhlen, P J Schechter, et al.
Cell Death & Disease
|
May 8, 2015
Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice
G Bortolussi, E Codarin, G Antoniali, et al.
Page
of 9